UNSPSC 51112526: Uracil mustard or uramustine

This classification denotes a nitrogen mustard compound with the molecular formula C8H11Cl2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W7KQ46GJ8U, chemically known as 2,6-dihydroxy-5-bis(2-chloroethyl)aminopyrimidine but more generally known as uracil mustard, which bears US NIH Compound Identifier 6194. European Medicines Agency schedules Uracil mustard in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11383MIG.

The term URAMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). SMILES: CLCCN(CCCL)C1C(=O)[NH]C(=O)[NH]C1.

UNSPSC 51112526 Uracil mustard or uramustine, a Commodity code, encompasses pharmaceutical products procured by state health agencies for treatment programs. The Texas Health and Human Services Commission represents the primary recent issuing body under this code, soliciting vendor capabilities and market intelligence for direct-to-manufacturer prescription programs that bypass traditional pharmacy benefit managers and group purchasing organizations. State and local procurement in this category centers on securing pharmaceutical inventory and establishing contracting relationships that support cost management and prescription fulfillment efficiency within public health benefit programs.

The Texas HHS Commission issued a Request for Information (RFI HHS0017013) on April 3, 2026, seeking vendor experience with direct contracting for self-insured employers and health plans, negotiated net pricing models, and outcomes-based agreements. Geographic activity under the code centers on Texas. No formal competitive solicitations with response deadlines or award values have been posted; the current RFI functions as a preliminary market-intelligence phase designed to inform the state's future procurement strategy before issuing a formal RFP with established financial and temporal parameters.